Explore 3 Stock Ideas & Industry Insights Download Free Report
With aMarket Valuethat dominates the FTSE 100, moves in the stock have an outsized effect on the index.
The shares had jumped about 5% in pre-market trading on 30 October after the results, taking them toward their 200-day average for the first time since July from a level near 13,050p.
The group also sits at the intersection of two themes investors are weighing: ageing populations that raiseDemandfor chronic care products, and hospital and payer pressure on pricing. How the shares respond to those forces helps explain why they trend whenever medtech sentiment shifts.
AstraZeneca, the other large UK pharmaceutical stock, reported firm nine-month numbers on 30 October, which sets a contrast with GSK’s vaccine concerns.
The shares had come under pressure after the third-quarter report on 28 October because of declining vaccine sales, even though the quarter beat forecasts and guidance was reaffirmed.
The shares are still absorbing the late-October trading disclosure, when the FTSE 100 constituent lost more than 12% in a single session. That update showed third-quarter revenue of £2.87 billion and organic growth of 2.6%, below the 3.2% the market had expected. Pricing added …
• The company’s activity is linked to develops and supplies diagnostic products and services intended to support earlier detection and treatment of disease.
• The company’s activity is linked to develops light-activated antimicrobial therapies designed to reduce infections and support infection prevention.
• The company’s activity is linked to proteomics and biomarker services supporting pharmaceutical research, clinical development and precision medicine.
• The company’s activity is linked to design, manufacture and sale of minimally invasive surgical instruments, alongside original-equipmentManufacturingand precision engineering work.
We use some essential cookies to make this site work. We also set analytics and marketing cookies, described below, to understand how you use the site and to measure our advertising. For more detailed information, see our Cookie Policy, Privacy Policy and Terms and Conditions.
These cookies are necessary for core functionality, such as security, your shopping cart, remembering your cookie choice, and your progress through a report or free-trial request you started. They always need to be on.
We use analytics cookies to understand how visitors use the site — the pages visited, time spent, and where visitors came from.
These help us measure how effective our advertising is, such as recording actions you take after clicking one of our ads. If you don't enable this, you may still see our ads, but they won't be measured this way.
Please wait processing your request...
You are not subscribed for this report, Want to See?
One of our sales representative will contact you soon!
Welcome to Kalkine!
Download Free Report
Hi! How can we help you today?
Loading…